SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : qtrn(quintiles trans)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Todd Bishop who wrote (22)3/31/1999 12:39:00 AM
From: Andy H  Read Replies (1) of 105
 
Not sure why, but often when these mergers actually close, the survivor goes up. I assume it has to do with the unwinding of the arbitrage in which the acquiring co. stock was sold short to capture the deal "premium." What escapes me is that the arbitrage should be completed by merely delivering the new shares of QTRN received in exchange for the ENVY shares to cover the short. For whatever reason, it seems there is always new buying after the deal closes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News